The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCormack, J. E.
Right arrow Articles by Marrack, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCormack, J. E.
Right arrow Articles by Marrack, P. C.

The Journal of Immunology, Vol 150, Issue 9 3785-3792, Copyright © 1993 by American Association of Immunologists

ARTICLES

Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen

JE McCormack, JE Callahan, J Kappler and PC Marrack
Howard Hughes Medical Institute, Denver, CO.

It has been noted previously that superantigens can under different circumstances stimulate activation, expansion, anergy, and/or deletion of reactive T cells in vivo and in vitro. Here, we present a detailed examination of the expansion and deletion of T cells in vivo in response to the superantigens staphylococcal enterotoxin A (SEA) in the B10.BR mouse. Mice were either acutely or chronically exposed to varying doses of SEA, and the relative level of T cells bearing SEA- reactive V beta elements was followed over time in lymphocytes purified from peripheral blood, lymph nodes, mesenteric lymph nodes, and spleen. In most cases, an initial sharp rise in the proportion of reactive T cells was followed by a dramatic decline. Cells of the CD4+ and CD8+ lineages displayed subtle differences in their kinetics of activation and deletion, as well as their sensitivity to different doses of SEA. Furthermore, cells bearing either of two V beta elements previously characterized as SEA-reactive showed some differences in their responses to SEA treatment. Acute exposure usually caused the disappearance of only 50% to 70% of reactive T cells; however, chronic exposure to SEA caused almost complete deletion of target T cells. Deletion was evident even in animals treated with very low doses of SEA, doses that were too small to cause any apparent T cell proliferation. Thus, proliferation does not appear to be a prerequisite for peripheral deletion of T cells.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
J. P. McAleer, D. J. Zammit, L. Lefrancois, R. J. Rossi, and A. T. Vella
The Lipopolysaccharide Adjuvant Effect on T Cells Relies on Nonoverlapping Contributions from the MyD88 Pathway and CD11c+ Cells
J. Immunol., November 15, 2007; 179(10): 6524 - 6535.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Sengupta, P. Jayaraman, P. M. Chilton, C. R. Casella, and T. C. Mitchell
Unrestrained Glycogen Synthase Kinase-3beta Activity Leads to Activated T Cell Death and Can Be Inhibited by Natural Adjuvant
J. Immunol., May 15, 2007; 178(10): 6083 - 6091.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Faulkner, A. Cooper, C. Fantino, D. M. Altmann, and S. Sriskandan
The Mechanism of Superantigen-Mediated Toxic Shock: Not a Simple Th1 Cytokine Storm
J. Immunol., November 15, 2005; 175(10): 6870 - 6877.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S.-J. Lee, L. Myers, G. Muralimohan, J. Dai, Y. Qiao, Z. Li, R. S. Mittler, and A. T. Vella
4-1BB and OX40 Dual Costimulation Synergistically Stimulate Primary Specific CD8 T Cells for Robust Effector Function
J. Immunol., September 1, 2004; 173(5): 3002 - 3012.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. R. Maxwell, R. J. Rossi, S. J. McSorley, and A. T. Vella
T Cell Clonal Conditioning: A Phase Occurring Early after Antigen Presentation but before Clonal Expansion Is Impacted by Toll-Like Receptor Stimulation
J. Immunol., January 1, 2004; 172(1): 248 - 259.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
E. Canto, J. L. Rodriguez-Sanchez, and S. Vidal
Distinctive response of naive lymphocytes from cord blood to primary activation via TCR
J. Leukoc. Biol., December 1, 2003; 74(6): 998 - 1007.
[Abstract] [Full Text]

Home page
 BloodHome page
N. Yawalkar, K. Ferenczi, D. A. Jones, K. Yamanaka, K.-Y. Suh, S. Sadat, and T. S. Kupper
Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma
Blood, December 1, 2003; 102(12): 4059 - 4066.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Myers, C. Takahashi, R. S. Mittler, R. J. Rossi, and A. T. Vella
Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering
PNAS, April 29, 2003; 100(9): 5348 - 5353.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Suresh, M. Vig, S. Bhatia, E. P. B. Goodspeed, B. John, U. Kandpal, S. Srivastava, A. George, R. Sen, V. Bal, et al.
Pentoxifylline Functions As an Adjuvant In Vivo to Enhance T Cell Immune Responses by Inhibiting Activation-Induced Death
J. Immunol., October 15, 2002; 169(8): 4262 - 4272.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Spaner, X. Sheng-Tanner, and A. C. Schuh
Aberrant regulation of superantigen responses during T-cell reconstitution and graft-versus-host disease in immunodeficient mice
Blood, August 28, 2002; 100(6): 2216 - 2224.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. R. Maxwell, C. Ruby, N. I. Kerkvliet, and A. T. Vella
Contrasting the Roles of Costimulation and the Natural Adjuvant Lipopolysaccharide During the Induction of T Cell Immunity
J. Immunol., May 1, 2002; 168(9): 4372 - 4381.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Chen, M. Koyanagi, K. Fukada, K.'i. Imanishi, J. Yagi, H. Kato, T. Miyoshi-Akiyama, R. Zhang, K. Miwa, and T. Uchiyama
Continuous Exposure of Mice to Superantigenic Toxins Induces a High-Level Protracted Expansion and an Immunological Memory in the Toxin-Reactive CD4+ T Cells
J. Immunol., April 15, 2002; 168(8): 3817 - 3824.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. Epelman, G. G. Neely, L. L. Ma, M. Gjomarkaj, E. Pace, M. Melis, D. E. Woods, and C. H. Mody
Distinct fates of monocytes and T cells directly activated by Pseudomonas aeruginosa exoenzyme S
J. Leukoc. Biol., March 1, 2002; 71(3): 458 - 468.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
W. Stohl, D. Xu, S. Zang, K. S. Kim, L. Li, J. A. Hanson, S. A. Stohlman, C. S. David, and C. O. Jacob
In vivo staphylococcal superantigen-driven polyclonal Ig responses in mice: dependence upon CD4+ cells and human MHC class II
Int. Immunol., October 1, 2001; 13(10): 1291 - 1300.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. M. O'Herrin, J. E. Slansky, Q. Tang, M. A. Markiewicz, T. F. Gajewski, D. M. Pardoll, J. P. Schneck, and J. A. Bluestone
Antigen-Specific Blockade of T Cells In Vivo Using Dimeric MHC Peptide
J. Immunol., September 1, 2001; 167(5): 2555 - 2560.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Tanchot, D. L. Barber, L. Chiodetti, and R. H. Schwartz
Adaptive Tolerance of CD4+ T Cells In Vivo: Multiple Thresholds in Response to a Constant Level of Antigen Presentation
J. Immunol., August 15, 2001; 167(4): 2030 - 2039.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Radoja, M. Saio, and A. B. Frey
CD8+ Tumor-Infiltrating Lymphocytes Are Primed for Fas-Mediated Activation-Induced Cell Death But Are Not Apoptotic In Situ
J. Immunol., May 15, 2001; 166(10): 6074 - 6083.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. De Panfilis, A. Caruso, P. Sansoni, G. Pasolini, D. Semenza, and C. Torresani
Identification of Fas-L-Expressing Apoptotic T Lymphocytes in Normal Human Peripheral Blood : In Vivo Suicide
Am. J. Pathol., February 1, 2001; 158(2): 387 - 391.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
C. Maranon, L. Planelles, C. Alonso, and M. C. Lopez
HSP70 from Trypanosoma cruzi is endowed with specific cell proliferation potential leading to apoptosis
Int. Immunol., December 1, 2000; 12(12): 1685 - 1693.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
K. L. Legge, B. Min, J. J. Bell, J. C. Caprio, L. Li, R. K. Gregg, and H. Zaghouani
Coupling of Peripheral Tolerance to Endogenous Interleukin 10 Promotes Effective Modulation of Myelin-activated T Cells and Ameliorates Experimental Allergic Encephalomyelitis
J. Exp. Med., June 12, 2000; 191(12): 2039 - 2052.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
T. K. Teague, B. C. Schaefer, D. Hildeman, J. Bender, T. Mitchell, J. W. Kappler, and P. Marrack
Activation-induced Inhibition of Interleukin 6-mediated T Cell Survival and Signal Transducer and Activator of Transcription 1 Signaling
J. Exp. Med., March 13, 2000; 191(6): 915 - 926.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. J. Adler, C.-T. Huang, G. S. Yochum, D. W. Marsh, and D. M. Pardoll
In Vivo CD4+ T Cell Tolerance Induction Versus Priming Is Independent of the Rate and Number of Cell Divisions
J. Immunol., January 15, 2000; 164(2): 649 - 655.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
A. A. Vandenbark, D. Barnes, T. Finn, D. N. Bourdette, R. Whitham, I. Robey, J. Kaleeba, B. F. Bebo Jr, S. D. Miller, H. Offner, et al.
Differential susceptibility of human Th1 versus T h 2 cells to induction of anergy and apoptosis by ECDI/antigen-coupled antigen-presenting cells
Int. Immunol., January 1, 2000; 12(1): 57 - 66.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. R. Maxwell, A. Weinberg, R. A. Prell, and A. T. Vella
Danger and OX40 Receptor Signaling Synergize to Enhance Memory T Cell Survival by Inhibiting Peripheral Deletion
J. Immunol., January 1, 2000; 164(1): 107 - 112.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
K. Szczepanska, Z. Chrzanowska-lightowlers, B. A. Degnan, A. G. Diamond, T. Robson, A. Ryzewska, and J. A. Goodacre
Th1-type cytokine mRNA in rheumatoid arthritis mononuclear cells induced by streptococcal pyrogenic exotoxin A
Rheumatology, October 1, 1999; 38(10): 1022 - 1024.
[Full Text] [PDF]

Home page
 JEMHome page
C. Miller, J. A. Ragheb, and R. H. Schwartz
Anergy and Cytokine-mediated Suppression as Distinct Superantigen-induced Tolerance Mechanisms In Vivo
J. Exp. Med., July 5, 1999; 190(1): 53 - 64.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. L. Legge, B. Min, C. Pack, J. Caprio, and H. Zaghouani
Differential Presentation of an Altered Peptide Within Fetal Central and Peripheral Organs Supports an Avidity Model for Thymic T Cell Development and Implies a Peripheral Readjustment for Activation
J. Immunol., May 15, 1999; 162(10): 5738 - 5746.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Takahashi, R. S. Mittler, and A. T. Vella
Cutting Edge: 4-1BB Is a Bona Fide CD8 T Cell Survival Signal
J. Immunol., May 1, 1999; 162(9): 5037 - 5040.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Mitchell, J. Kappler, and P. Marrack
Bystander Virus Infection Prolongs Activated T Cell Survival
J. Immunol., April 15, 1999; 162(8): 4527 - 4535.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Matloubian, M. Suresh, A. Glass, M. Galvan, K. Chow, J. K. Whitmire, C. M. Walsh, W. R. Clark, and R. Ahmed
A Role for Perforin in Downregulating T-Cell Responses during Chronic Viral Infection
J. Virol., March 1, 1999; 73(3): 2527 - 2536.
[Abstract] [Full Text]

Home page
 Int ImmunolHome page
A. Le Bon, A.-C. Wache, and M. Papiernik
In vivo elimination of viral superantigen-activated CD4+ T cells: apoptosis occurs at a distance from the activation site
Int. Immunol., March 1, 1999; 11(3): 373 - 382.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. R. Maxwell, J. D. Campbell, C. H. Kim, and A. T. Vella
CD40 Activation Boosts T Cell Immunity In Vivo by Enhancing T Cell Clonal Expansion and Delaying Peripheral T Cell Deletion
J. Immunol., February 15, 1999; 162(4): 2024 - 2034.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
P. Marrack, J. Kappler, and T. Mitchell
Type I Interferons Keep Activated T Cells Alive
J. Exp. Med., February 1, 1999; 189(3): 521 - 530.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. R.M. Bennett, F. R. Carbone, T. Toy, J. F.A.P. Miller, and W. R. Heath
B Cells Directly Tolerize CD8+ T Cells
J. Exp. Med., December 7, 1998; 188(11): 1977 - 1983.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. M. Spiekermann and C. Nagler-Anderson
Oral Administration of the Bacterial Superantigen Staphylococcal Enterotoxin B Induces Activation and Cytokine Production by T Cells in Murine Gut-Associated Lymphoid Tissue
J. Immunol., December 1, 1998; 161(11): 5825 - 5831.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z.-C. Kou, M. Halloran, D. Lee-Parritz, L. Shen, M. Simon, P. K. Sehgal, Y. Shen, and Z. W. Chen
In Vivo Effects of a Bacterial Superantigen on Macaque TCR Repertoires
J. Immunol., May 15, 1998; 160(10): 5170 - 5180.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Fournel, E. Robinet, N. Bonnefoy-Berard, O. Assossou, M. Flacher, H. Waldmann, G. Bismuth, and J.-P. Revillard
A Noncomitogenic CD2R Monoclonal Antibody Induces Apoptosis of Activated T Cells by a CD95/CD95-L-Dependent Pathway
J. Immunol., May 1, 1998; 160(9): 4313 - 4321.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. T. Vella, S. Dow, T. A. Potter, J. Kappler, and P. Marrack
Cytokine-induced survival of activated T cells in vitro and in vivo
PNAS, March 31, 1998; 95(7): 3810 - 3815.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
W. A. Ferens, W. C. Davis, M. J. Hamilton, Y. H. Park, C. F. Deobald, L. Fox, and G. Bohach
Activation of Bovine Lymphocyte Subpopulations by Staphylococcal Enterotoxin C
Infect. Immun., February 1, 1998; 66(2): 573 - 580.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Noble, G. A. Pestano, and H. Cantor
Suppression of Immune Responses by CD8 Cells. I. Superantigen-Activated CD8 Cells Induce Unidirectional Fas-Mediated Apoptosis of Antigen-Activated CD4 Cells
J. Immunol., January 15, 1998; 160(2): 559 - 565.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
H. C. DeGrendele, P. Estess, and M. H. Siegelman
Requirement for CD44 in Activated T Cell Extravasation into an Inflammatory Site
Science, October 24, 1997; 278(5338): 672 - 675.
[Abstract] [Full Text]

Home page
 JEMHome page
L. S. Cauley, K. A. Cauley, F. Shub, G. Huston, and S. L. Swain
Transferable Anergy: Superantigen Treatment Induces CD4+ T Cell Tolerance That Is Reversible and Requires CD4-CD8- Cells and Interferon gamma
J. Exp. Med., July 7, 1997; 186(1): 71 - 81.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
A. R. A. Hamad, P. Marrack, and J. W. Kappler
Transcytosis of Staphylococcal Superantigen Toxins
J. Exp. Med., April 21, 1997; 185(8): 1447 - 1454.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
S Nagata and P Golstein
The Fas death factor
Science, March 10, 1995; 267(5203): 1449 - 1456.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.